A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.
PHASE1CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
March 31, 2006
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2006
Conditions
Tuberculosis
Interventions
DRUG
PA-824
Trial Locations (1)
53704
Covance Clinical Research Unit, Madison
All Listed Sponsors
lead
Global Alliance for TB Drug Development
OTHER
NCT03202693 - A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects. | Biotech Hunter | Biotech Hunter